Dosage and administration
Adults and children over 12: Spray twice under the tongue 3 times per day. Children 12 and under: Consult a doctor prior to use.
Incontinence
- Manufacturer
- Liddell Laboratories, Inc. | Apotheca Company
- Effective date
- 2022-06-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:57:41
Label at a glance#
ProductIncontinence
Active ingredientATROPA BELLADONNA, LYTTA VESICATORIA, CAUSTICUM, ARTEMISIA CINA PRE-FLOWERING TOP, EQUISETUM HYEMALE, STRYCHNOS IGNATII SEED, PHYSALIS ALKEKENGI FRUIT, SEPIA OFFICINALIS JUICE, PULSATILLA PRATENSIS WHOLE, VERBASCUM THAPSUS
Label structure9 sections
Contacts and useful links#
Websitewww.liddell.net
WWW.LIDDELL.NET
WWW.LIDDELL.NETLabel contents#
Full prescribing information#
ACTIVE INGREDIENTS:
(in each spray) 10% of Belladonna 200C, Cantharis 200C, Causticum 200C, Cina 6X, Equisetum hyemale 3X, Ignatia amara 200C, Physalis alkekengi 6X, Sepia 200C, Pulsatilla (pratensis) 10X, Verbascum thapsus 3X.
INDICATIONS:
May temporarily relieve symptoms associated with abnormal bladder function.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
WARNINGS:
If symptoms persist for more that 7 days, consult a doctor.
If pregnant or breast feeding, ask a doctor before use.
Keep out of reach of children. In case of overdose, get medical help or call a Poison Control Center right away.
Do not use if TAMPER EVIDENT seal around neck of bottle is missing or broken.
KEEP OUT OF REACH OF CHILDREN:
Keep out of reach of children. In case of overdose, get medical help or call a Poison Control Center right away.
DIRECTIONS:
Adults and children over 12: Spray twice under the tongue 3 times per day.
Children 12 and under: Consult a doctor prior to use.
INDICATIONS:
May temporarily relieve symptoms associated with abnormal bladder function.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
INACTIVE INGREDIENTS:
Organic alcohol 20% v/v, Purified water.
QUESTIONS:
PACKAGE LABEL DISPLAY:
ORAL SPRAYS
LIDDELL LABORATORIES
EST. 1994
29 In
Incontinence
HOMEOPATHIC
1.0 FL. OZ. (30 ml)
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50845-0258-1 | 2022-06-30 | C162847 | 48780-1 | d6a99b39-8749-a426-e053-dadaa90af4c2 | Drug Facts: |
| 50845-0258-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-8749-a426-e053-dadaa90af4c2 | Drug Facts: |
Products#
Every source-derived product name is available through these pages.
- Incontinence
- Belladonna, Cantharis, Causticum, Cina, Equisetum hyemale, Ignatia amara, Physalis alkekengi, Sepia, Pulsatilla (pratensis), Verbascum thapsus
- ATROPA BELLADONNA
- LYTTA VESICATORIA
- CAUSTICUM
- ARTEMISIA CINA PRE-FLOWERING TOP
- ARTEMISIA CINA FLOWER
- EQUISETUM HYEMALE
- STRYCHNOS IGNATII SEED
- PHYSALIS ALKEKENGI FRUIT
- SEPIA OFFICINALIS JUICE
- PULSATILLA PRATENSIS WHOLE
- VERBASCUM THAPSUS
- WATER
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50845-0258 | 50845-0258-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ATROPA BELLADONNA | WQZ3G9PF0H | ACTIB |
| LYTTA VESICATORIA | 3Q034RO3BT | ACTIB |
| CAUSTICUM | DD5FO1WKFU | ACTIB |
| ARTEMISIA CINA PRE-FLOWERING TOP | 28M1820ACT | ACTIB |
| EQUISETUM HYEMALE | 59677RXH25 | ACTIB |
| STRYCHNOS IGNATII SEED | 1NM3M2487K | ACTIB |
| PHYSALIS ALKEKENGI FRUIT | 2042VC712P | ACTIB |
| SEPIA OFFICINALIS JUICE | QDL83WN8C2 | ACTIB |
| PULSATILLA PRATENSIS WHOLE | 8E272251DI | ACTIB |
| VERBASCUM THAPSUS | C9TD27U172 | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5d7b1729-05fd-413b-8999-635af6b91950 | 53aae65c-14b0-447f-b84a-b5e091eaab8d | 2022-06-30 | Warnings | 5d7b1729-05fd-413b-8999-635af6b91950 53aae65c-14b0-447f-b84a-b5e091eaab8d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.